Paloma Partners Management CO Ascendis Pharma A/S Transaction History

Paloma Partners Management CO

  • $518 Million
  • Q1 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$112.67 - $176.92 $236,494 - $371,355
-2,099 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$121.62 - $145.29 $255,280 - $304,963
2,099 New
2,099 $276,000
Q1 2020

May 15, 2020
SELL
$97.01 - $145.11 $154,633 - $231,305
-1,594 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$91.45 - $139.12 $145,771 - $221,757
1,594 New
1,594 $222,000

Others Institutions Holding ASND

# of Institutions
270
Shares Held
61.9M
Call Options Held
151K
Put Options Held
226K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $8.89B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email